
1. Fed Pract. 2021 Jun;38(6):282-285. doi: 10.12788/fp.0137.

Treating Hepatitis C Virus Reinfection With 8 Weeks of Ledipasvir/Sofosbuvir
Achieves Sustained Virologic Response.

Rife KM(1), Lea EJ(1), Hirsch AA(1), Falck-Ytter Y(1).

Author information: 
(1)is a Hepatology Clinical Pharmacy Specialist, is an Infectious Diseases
Clinical Pharmacist, is the Chief of the Gastroenterology and Hepatology Section,
and is a Behavioral Health Psychologist, all at US Department of Veterans Affairs
Northeast Ohio Healthcare System in Cleveland. Yngve Falck-Ytter is a Professor
of Medicine, Erin Lea is an Adjunct Assistant Professor in the Department of
Psychological Sciences, and Amy Hirsch is a Senior Clinical Instructor in the
College of Medicine, all at Case Western Reserve University. Yngve Falck-Ytter is
Faculty for the Gastroenterology Fellowship Program at University Hospitals.

Three patients reinfected with hepatitis C virus after a sustained virologic
response were considered treatment naïve and treated with a short-course direct
acting antiviral regimen.

Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

DOI: 10.12788/fp.0137 
PMCID: PMC8560044
PMID: 34733076 

Conflict of interest statement: Author disclosures The authors report no actual
or potential conflicts of interest with regard to this article.

